Management Centre Europe | MCE | Organizational and Management Development - Strategy Execution

Genzyme Europe

Advanced Project and Programme Management for Clinical Studies

Genzyme is one of the world’s leading biotechnology companies. It has more than 10,000 employees throughout the world who are united by a common goal: to make a major positive impact on the lives of people with debilitating diseases.

Why did Genzyme Europe contact MCE?

Project and programme management are increasingly important for biotechnology, healthcare and life sciences companies. Genzyme Europe wanted to bring in external expertise to work with its people to fine-tune their skills and make sure that they were up-to-date with the very latest thinking and best practice in these areas. This would help Genzyme Europe to maintain its own standards of excellence in line with project and programme governance structures in the industry. Genzyme Europe identified five solution providers. Based upon an RFP (request for proposal) and an MCE demonstration, Genzyme Europe selected MCE to provide the external expertise it required.

How did MCE work with Genzyme Europe?



Deciding on the right Strategy Implementation Programme for Genzyme Europe

“Both workshops were very successful and triggered constructive discussions during and after the session. We are now applying what we learnt in the workshop to our project and programme management activities.”
Roelf Zondag, Clinical Operations Director, Genzyme Europe
 

The MCE Associate, who now felt that he had sufficient information to progress, met with Mr Zondag and a group of Genzyme Europe directors and managers to review the proposal that he had put together. He also gave a demo to the group to show MCE’s interactive and practical approach to development. Genzyme Europe were happy with the proposal and demo. They agreed that the best solution would be a workshop on advanced project and programme management for conducting clinical studies.



Results and Benefits for Genzyme Europe

Clinical Operations Director Roelf Zondag explained: “Both workshops were very successful and triggered constructive discussions during and after the session. We are now applying what we learned in the workshop to our project and programme management activities.”

Key success criteria included:

  • An understanding by everyone of when to apply project management and when to apply programme management
  • The consistent application of risk management practices for projects and programmes – to ensure best results
  • More delegation from team members when carrying out projects and programmes
  • The application of steering projects and programmes via performance indicators and metrics

Project Management vs. Programme Management

About Genzyme

Since its founding in 1981, Genzyme has grown from a small start-up to a diversified enterprise with revenues of $3.8 billion in 2007. Over the past two decades Genzyme has introduced a number of breakthrough treatments in several areas of medicine, which have provided hope to patients who previously had no viable treatment options. Genzyme products are helping patients in nearly 90 countries. Genzyme aims to continue to expand its global infrastructure and invest in both internal R&D and acquisitions. It is well-positioned for future growth, with one major new product launched in 2006, a number of significant products early in their lifecycle, and approximately 20 pivotal clinical studies for new products and indications underway or about to begin.
www.Genzyme.com